Expression and Clinical Significance of NF-κB and ICAM-1 in Non-Small Cell Lung Cancer

ZENG Xu,LUO Bai-ling
DOI: https://doi.org/10.3969/j.issn.1005-8982.2005.14.020
2005-01-01
Abstract:【Objective】 To investigate the clinical significance of NF-кB and ICAM-1 in non-small cell lung cancer (NSCLC). 【Methods】 The expression of NF-кBp65 and ICAM-1 were detected by SABC immunohistochemistry method in paraffin-embeded sample from 40 cases of NSCLC to analyzed the correlation between NF-кBp65, ICAM-1 and kinds of clinical factors(including sex, age, histological type, cell differentiation, tumor size, TNM stage, cigarette index and distant metastasis). 40 cases of non-malignant tissue from lung lesions were employed as a control group. 【Results】 NF-кBp65 and ICAM-l were evidently expressed and were more strongly expressed in lung cancer than in non-malignant tissue (P<0.05). In lung cancer, the expression of NF-кBp65 and I- CAM-1 in adenocarcinoma was stronger than in squamous cell carcinoma. The expression of ICAM-1 in poorly differentiated tumor tissues was stronger than in well differentiated tumor tissues (P<0.05). NF-кBp65 and ICAM-1 were more strongly expressed in lung cancer with distant metastasis than those without distant metastasis (P<0.05). The expression of NF-кBp65 and ICAM-1 were not related to age, sex, tumor size, stage and cigarette index (P>0.05). In NSCLC tissue, there was positive correlation between NF-кBp65 and ICAM-1 (P<0.05). 【Conclusions】 It was strongly expressed the expression of NF-кBp65 and ICAM-1. The expression of NF-кBp65 and ICAM-1 had relation with the invasion and metastasis of lung cancer. And in NSCLC tissue, there was positive correlation between NF-кBp65 and ICAM-1.
What problem does this paper attempt to address?